Klinikum der Universität München (LMU Klinikum)

PRECYCLE Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy (2019) Degenhardt T, Fasching P, Lueftner D, Mueller V, Thomssen C, Schem C, Witzel I, et al. Conference contribution Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI (2019) Mulay SR, Honarpisheh MM, Foresto-Neto O, Shi C, Desai J, Zhao ZB, Marschner JA, et al. Journal article Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients (2019) Nicosia L, Mazzola R, Rigo M, Figlia V, Giaj-Levra N, Napoli G, Ricchetti F, et al. Journal article Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Actinic keratosis and cutaneous squamous cell carcinoma - Treatment options Aktinische Keratose und kutanes Plattenepithelkarzinom (2019) Gutzmer R, Wiegand S, Koelbl O, Wermker K, Hepp M, Berking C Journal article Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks (2019) Maron RC, Weichenthal M, Utikal JS, Hekler A, Berking C, Hauschild A, Enk AH, et al. Journal article Deep neural networks are superior to dermatologists in melanoma image classification (2019) Brinker TJ, Hekler A, Enk AH, Berking C, Haferkamp S, Hauschild A, Weichenthal M, et al. Journal article Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data (2019) Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, et al. Journal article Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma (2019) Fleischmann DF, Jenn J, Corradini S, Ruf V, Herms J, Forbrig R, Unterrainer M, et al. Journal article